US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CERo Therapeutics Holdings, Inc.

0.8918

+0.00190.21%

Post-market: 0.8600-0.0318-3.57%19:53 EDT

Volume:404.92K

Turnover:357.68K

Market Cap:4.80M

PE:-0.03

High:0.9074

Open:0.8700

Low:0.8649

Close:0.8899

Loading ...

Overview Company News Filings

Cero Therapeutics files to sell 210M shares of common stock for holders

Cero Therapeutics Holdings - Potential Offer and Sale of up to 210 Mln Shares by Keystone Capital Partners

THOMSON REUTERS

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live

Sector Update: Health Care Stocks Retreat Friday Afternoon

MT Newswires Live

CERo Says US FDA Clears Investigational New Drug Application to Launch Leukemia Treatment Trial; Shares Soar

MT Newswires Live

Cero Therapeutics receives FDA clearance of IND application for CER-1236

Cero Therapeutics Holdings Inc - to Initiate Phase 1 Trials for Cer-1236 in Early 2025

THOMSON REUTERS

Cero Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound Cer-1236 in Acute Myelogenous Leukemia

THOMSON REUTERS

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

Cero Therapeutics Officer YK Bioventures Opportunities GP I, LLC Sold 3,250,000 Shares

CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live

Top Midday Gainers

MT Newswires Live

Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results

Cero Therapeutics presents preclinical data on CER-1236

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CERO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CERO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CERO\",,,,,undefined,":{"symbol":"CERO","market":"US","secType":"STK","nameCN":"CERo Therapeutics Holdings, Inc.","latestPrice":0.8918,"timestamp":1746129600000,"preClose":0.8899,"halted":0,"volume":404920,"hourTrading":{"tag":"盘后","latestPrice":0.86,"preClose":0.8918,"latestTime":"19:53 EDT","volume":11864,"amount":10244.583709,"timestamp":1746143585702},"delay":0,"floatShares":4381676,"shares":5380723,"eps":-27.83886,"marketStatus":"Not Yet Opened","change":0.0019,"latestTime":"05-01 16:00:00 EDT","open":0.87,"high":0.9074,"low":0.8649,"amount":357681.951816,"amplitude":0.047758,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-27.83886,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746172800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.8899,"preHourTrading":{"tag":"盘前","latestPrice":0.9,"preClose":0.8899,"latestTime":"09:28 EDT","volume":6214,"amount":5555.6711301,"timestamp":1746106082255},"postHourTrading":{"tag":"盘后","latestPrice":0.86,"preClose":0.8918,"latestTime":"19:53 EDT","volume":11864,"amount":10244.583709,"timestamp":1746143585702},"volumeRatio":0.026984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CERO\",,,,,undefined,":{"symbol":"CERO","floatShares":4381676,"roa":"-178.66%","roe":"--","lyrEps":-38.847442,"volumeRatio":0.026984,"shares":5380723,"dividePrice":0,"high":0.9074,"amplitude":0.047758,"preClose":0.8899,"low":0.8649,"week52Low":0.5338,"pbRate":"-0.95","week52High":147,"institutionHeld":0,"latestPrice":0.8918,"eps":-27.83886,"divideRate":0,"volume":404920,"delay":0,"ttmEps":-27.83886,"open":0.87,"prevYearClose":6,"prevWeekClose":0.8901,"prevMonthClose":0.8899,"prevQuarterClose":0.73,"fiveDayClose":1.11,"twentyDayClose":0.729,"sixtyDayClose":1.98},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CERO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2486384089","title":"Cero Therapeutics files to sell 210M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2486384089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486384089?lang=en_us&edition=fundamental","pubTime":"2024-11-27 19:25","pubTimestamp":1732706708,"startTime":"0","endTime":"0","summary":"06:23 EST Cero Therapeutics (CERO) files to sell 210M shares of common stock for holders Published first on TheFly – the ultimate source for real-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-files-to-sell-210m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-files-to-sell-210m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2486847869","title":"Cero Therapeutics Holdings - Potential Offer and Sale of up to 210 Mln Shares by Keystone Capital Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2486847869","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486847869?lang=en_us&edition=fundamental","pubTime":"2024-11-27 19:22","pubTimestamp":1732706571,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nFWN3MY0N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2483578538","title":"Sector Update: Health Care Stocks Slide Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2483578538","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483578538?lang=en_us&edition=fundamental","pubTime":"2024-11-16 05:01","pubTimestamp":1731704517,"startTime":"0","endTime":"0","summary":"Health care stocks fell late Friday afternoon with the NYSE Health Care Index declining 1.7% and the Health Care Select Sector SPDR Fund  dropping 1.8%.The iShares Biotechnology ETF  slumped 4.7%.In corporate news, Eyenovia  shares plunged 69%. A phase 3 study evaluating the drug-device combination of low-dose atropine in the company's Optejet dispensing platform for pediatric progressive myopia didn't meet the primary endpoint. Eyenovia also is considering options including a business combination, reverse merger or asset sales.Bluebird Bio  shares sank 11% after BofA Securities downgraded the company's stock to neutral from buy.Halozyme Therapeutics  offered to buy German drugmaker Evotec  for 2 billion euros . Halozyme shares tumbled 15%, and Evotec jumped past 6%.CERo Therapeutics  shares surged 52%. The US Food and Drug Administration cleared the company's investigational new drug application for a phase 1 trial of its lead compound CER-1236 to treat acute myelogenous leukemia.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BLUE","BK4578","BK4007","BK4588","BK4139","EVO","BK7132","IBB","XLV","EVO.AU","BK4556","BK4121","CERO","HALO","BK4581","LU0053671581.USD","EYEN"],"gpt_icon":1},{"id":"2483586344","title":"Sector Update: Health Care Stocks Retreat Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2483586344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483586344?lang=en_us&edition=fundamental","pubTime":"2024-11-16 02:52","pubTimestamp":1731696773,"startTime":"0","endTime":"0","summary":"Health care stocks fell Friday afternoon with the NYSE Health Care Index declining 1.5% and the Health Care Select Sector SPDR Fund  dropping 1.6%.The iShares Biotechnology ETF  slumped 4.3%.In corporate news, Moderna  shares fell 6.4%, Pfizer  dropped 4.5% and Novavax  shed 1.1% after US President-elect Donald Trump's nomination of anti-vaccination activist Robert F. Kennedy Jr. to lead the Department of Health and Human Services.Halozyme Therapeutics  offered to buy German drugmaker Evotec  for 2 billion euros . Halozyme shares tumbled 14%, and Evotec jumped past 7.7%.CERo Therapeutics  shares surged 62%. The US Food and Drug Administration cleared the company's investigational new drug application for a phase 1 trial of its lead compound CER-1236 to treat acute myelogenous leukemia.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","BK4532","LU0456855351.SGD","BK7095","EVO.AU","HALO","BK4551","LU0225771236.USD","LU1894683264.USD","MRNA","BK4139","PFE.AU","LU0306806265.USD","BK4592","LU0306807586.USD","LU1023059063.AUD","LU0985481810.HKD","LU0122379950.USD","LU0234572021.USD","BK4588","SG9999013999.USD","LU1883839398.USD","BK4534","LU0170899867.USD","BK4548","LU0225284248.USD","IE00B19Z3B42.SGD","SG9999002232.USD","CERO","LU0053671581.USD","LU1057294990.SGD","LU0058720904.USD","BK4581","SG9999001176.SGD","XLV","NVAX","EVO","BK4121","LU0321505439.SGD","SG9999002224.SGD","BK4568","IE0002270589.USD","IBB","LU1066051498.USD","LU1894683348.USD","BK4550","PFE","IE00BLSP4239.USD","LU0321505868.SGD","BK7132"],"gpt_icon":1},{"id":"2483370082","title":"CERo Says US FDA Clears Investigational New Drug Application to Launch Leukemia Treatment Trial; Shares Soar","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370082","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483370082?lang=en_us&edition=fundamental","pubTime":"2024-11-15 23:05","pubTimestamp":1731683140,"startTime":"0","endTime":"0","summary":"CERo Therapeutics Holdings  said Friday that the US Food and Drug Administration has cleared its investigational new drug application for a phase 1 trial of its lead compound CER-1236 to treat acute myelogenous leukemia.The company said it expects to start the phase 1 trial in Q1 of 2025.CERo's shares soared past 79% in recent trading.Price: 0.34, Change: +0.15, Percent Change: +79.22","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2483792463","title":"Cero Therapeutics receives FDA clearance of IND application for CER-1236","url":"https://stock-news.laohu8.com/highlight/detail?id=2483792463","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483792463?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:50","pubTimestamp":1731678633,"startTime":"0","endTime":"0","summary":"CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug Application for Ph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-receives-fda-clearance-of-ind-application-for-cer-1236?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-receives-fda-clearance-of-ind-application-for-cer-1236?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CERO","LENZ"],"gpt_icon":0},{"id":"2483764703","title":"Cero Therapeutics Holdings Inc - to Initiate Phase 1 Trials for Cer-1236 in Early 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2483764703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483764703?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:45","pubTimestamp":1731678300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA4SN3K9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2483376477","title":"Cero Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound Cer-1236 in Acute Myelogenous Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483376477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483376477?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:45","pubTimestamp":1731678300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA4SN3K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2483371353","title":"CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483371353","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483371353?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:45","pubTimestamp":1731678300,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024  -- CERo Therapeutics Holdings, Inc.  , an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics augmented with phagocytic mechanisms derived from the innate arm of the immune system, announces that the U.S. Food and Drug Administration  has cleared the Company’s Investigational New Drug Application  for Phase 1 clinical trials of its lead compound, CER-1236, in acute myelogenous leukemia .Forward-Looking StatementsThis communication contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy, clinical development of CER-1236, the potential benefits of CER-1236 in AML, and the plans and objectives of management for future operations of CERo. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statemen","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/T6sFa8GpShiuFtG._zLWDw--~B/aD00Mjk7dz04ODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d6252fbe33e9cbb1b271a88446c93bd3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/T6sFa8GpShiuFtG._zLWDw--~B/aD00Mjk7dz04ODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d6252fbe33e9cbb1b271a88446c93bd3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cero-therapeutics-inc-receives-fda-134500755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERO","LENZ","BK4139","CEROW"],"gpt_icon":0},{"id":"1179912983","title":"Cero Therapeutics Officer YK Bioventures Opportunities GP I, LLC Sold 3,250,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1179912983","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179912983?lang=en_us&edition=fundamental","pubTime":"2024-11-15 09:15","pubTimestamp":1731633349,"startTime":"0","endTime":"0","summary":"Cero Therapeutics Holdings, Inc.  Officer YK Bioventures Opportunities GP I, LLC sold 3,250,000 shares of common stock on October 10, 2024, at an average price of approximately $0.10 per share. Following this transaction, their indirect ownership stands at 22,620,783 shares. This sell-off by a senior officer may indicate a cautious outlook on the company's short-term prospects, and investors should consider this along with other market information before making investment decisions.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERO"],"gpt_icon":0},{"id":"2482757527","title":"CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2482757527","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482757527?lang=en_us&edition=fundamental","pubTime":"2024-11-12 17:41","pubTimestamp":1731404493,"startTime":"0","endTime":"0","summary":"CERo Therapeutics stock is rising higher on Monday as investors react to the latest preclinical data concerning lead compound CER-1236.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/cero-therapeutics-cero-stock-sees-significant-climb-after-revealing-ovarian-cancer-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/cero-therapeutics-cero-stock-sees-significant-climb-after-revealing-ovarian-cancer-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CERO"],"gpt_icon":0},{"id":"2482763981","title":"Sector Update: Health Care Stocks Softer Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2482763981","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482763981?lang=en_us&edition=fundamental","pubTime":"2024-11-12 04:57","pubTimestamp":1731358626,"startTime":"0","endTime":"0","summary":"Health care stocks fell late Monday afternoon with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund  shedding 0.7%.The iShares Biotechnology ETF  declined 0.6%.In corporate news, Evotec  shares surged 18% after Bloomberg reported the company is the subject of a potential takeover bid by Triton Partners.RAPT Therapeutics  shares plunged 39% after the company said Monday it's ending its zelnecirnon program after the US Food and Drug Administration put a hold on two trials assessing the drug as a potential treatment for asthma and atopic dermatitis.CERo Therapeutics  shares soared 165%. The company said Monday that it presented preclinical data demonstrating the capability of its lead compound CER-1236 to kill ovarian cancer cells in preclinical models with no indications of toxicity in animal models.AbbVie  shares tumbled 12%. The company said its two phase 2 trials assessing emraclidine in adult patients with schizophrenia and acute exacerbation of psycho","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0861579265.USD","IE00BJJMRZ35.SGD","LU0738911758.USD","RAPT","LU0029864427.USD","XLV","IE0009355771.USD","LU0211327993.USD","BK4121","LU1003077747.HKD","LU0170899867.USD","BK4550","EVO.AU","LU0820561909.HKD","LU0965509010.AUD","LU0203345920.USD","BK7132","IE00BDGV0183.EUR","LU0310799852.SGD","LU0456855351.SGD","LU0198837287.USD","LU0545039389.USD","LU0795875169.SGD","LU0965508806.USD","BK4559","LU0128525929.USD","EVO","LU0256863811.USD","LU0553294199.USD","LU1023059063.AUD","CERO","BK4534","LU0708994859.HKD","BK4566","LU0912757837.SGD","LU0114720955.EUR","BK4581","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","IBB","LU0795875086.SGD","LU0943347566.SGD","LU0203347892.USD","LU0661504455.SGD","LU0211328371.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","ABBV","LU0256863902.USD"],"gpt_icon":0},{"id":"2482675434","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2482675434","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482675434?lang=en_us&edition=fundamental","pubTime":"2024-11-12 03:08","pubTimestamp":1731352135,"startTime":"0","endTime":"0","summary":"CERo Therapeutics  said on Monday that it presented preclinical data demonstrating the capability of its lead compound CER-1236 to kill ovarian cancer cells in preclinical models with no indications of toxicity in animal models.Shares surged 140% as intraday trading volume soared to more than 1.16 billion from a daily average of about 8.8 million.RadNet  shares soared as Q3 adjusted earnings and revenue reported late Sunday rose more than forecast.Shares advanced 20% as intraday trading volume climbed to over 1.8 million from a daily average of about 523,000.Jefferies was one of several brokerage firms to adjust its price target for Bristol-Myers Squibb . It raised the price target to $63 from $58 while maintaining the hold rating.Shares of Bristol-Myers jumped 11%, with intraday trading volume at over 18.3 million compared with a daily average of about 10.6 million.Price: 0.17, Change: +0.10, Percent Change: +140.00","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU1032466523.USD","IE00BJJMRZ35.SGD","BK4585","LU2360032135.SGD","LU2242646821.SGD","IE0009355771.USD","LU2125154778.USD","LU1093756168.USD","LU1989771016.USD","LU0882574055.USD","LU1074936037.SGD","LU1670710661.SGD","LU0985481810.HKD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1093756325.SGD","BK4139","LU1670710588.SGD","BK4559","LU0306806265.USD","BK4532","LU1571399168.USD","IE00B2B36J28.USD","LU1670711040.USD","CERO","BK4534","LU2065731478.USD","LU2242652126.USD","LU1585245621.USD","LU0225771236.USD","LU0114720955.EUR","LU1261432733.SGD","BMY","BK4581","RDNT","LU1670711123.USD","IE00BSNM7G36.USD","LU1718418525.SGD","LU1430594728.SGD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","BK4196","LU0868494617.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2133065610.SGD","LU0061475181.USD"],"gpt_icon":0},{"id":"2482738020","title":"Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738020","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482738020?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:49","pubTimestamp":1731336596,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/11/41879774/dow-jumps-over-400-points-monday-com-shares-fall-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4206","RAPT","LU2357305700.SGD","BK4187","BK4082","BK4139","FOXO","BK4097","PSQ","MNQmain","LU1548497426.USD","MNDY","BK4590","LU2065171402.SGD","SQQQ","QLD","EFSH","LU2065169927.USD","BK4585","CERO","NXL","BK4023","LU1720051017.SGD","BK4588","BK4122","LU1720051108.HKD","HOVR","LU2065171311.SGD","LU2065170008.USD","NQmain","PCOM",".IXIC","QID","TQQQ"],"gpt_icon":1},{"id":"2482817227","title":"Cero Therapeutics presents preclinical data on CER-1236","url":"https://stock-news.laohu8.com/highlight/detail?id=2482817227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482817227?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:26","pubTimestamp":1731331563,"startTime":"0","endTime":"0","summary":"CERo Therapeutics (CERO) announces the presentation of preclinical data demonstrating the capability of its lead compound CER-1236 to kill ovarian ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-presents-preclinical-data-on-cer-1236?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-presents-preclinical-data-on-cer-1236?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","CERO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CERO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-08","symbol":"CERO","defaultRemindTime":1736346600000,"type":"split","dateTimestamp":1736312400000,"forFactor":100,"toFactor":1,"ratio":100},{"market":"US","date":"2024-02-15","symbol":"CERO","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CERO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CERO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CERO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CERO","date":"2025-04-30","current":-0.614112,"percent":0.839858,"low":-23.40166,"twenty":-8.011298,"median":-1.966295,"eighty":-0.672684,"high":-0.137942,"avg":-4.466468,"sd":5.002508,"marketCap":5099849},"quantilePoints":[{"date":"2024-02-23","current":-14.247617,"twenty":-20.956561,"median":-17.613942,"eighty":-14.944588,"marketCap":35849112},{"date":"2024-03-01","current":-17.506812,"twenty":-18.431546,"median":-15.409236,"eighty":-15.153206,"marketCap":44049729},{"date":"2024-03-08","current":-18.247371,"twenty":-17.820809,"median":-15.409236,"eighty":-15.203159,"marketCap":45913085},{"date":"2024-03-15","current":-13.270815,"twenty":-17.820809,"median":-15.409236,"eighty":-15.057448,"marketCap":33391335},{"date":"2024-03-22","current":-12.856102,"twenty":-17.518661,"median":-15.34438,"eighty":-13.839564,"marketCap":32347855},{"date":"2024-03-28","current":-9.656887,"twenty":-17.423869,"median":-15.187199,"eighty":-12.785008,"marketCap":24298158},{"date":"2024-04-05","current":-11.26226,"twenty":-17.423869,"median":-15.107401,"eighty":-12.559878,"marketCap":28563716},{"date":"2024-04-12","current":-10.85589,"twenty":-17.252059,"median":-14.262796,"eighty":-11.529063,"marketCap":27533066},{"date":"2024-04-19","current":-8.940145,"twenty":-16.820909,"median":-13.270815,"eighty":-10.646899,"marketCap":22674290},{"date":"2024-04-26","current":-8.185457,"twenty":-16.072132,"median":-12.878911,"eighty":-10.171589,"marketCap":20760226},{"date":"2024-05-03","current":-8.011298,"twenty":-15.61915,"median":-12.441389,"eighty":-9.218799,"marketCap":20318519},{"date":"2024-05-10","current":-6.676082,"twenty":-15.409236,"median":-11.944081,"eighty":-8.208678,"marketCap":16932099},{"date":"2024-05-17","current":-6.559976,"twenty":-15.406992,"median":-11.26226,"eighty":-8.011298,"marketCap":16637628},{"date":"2024-05-24","current":-5.773123,"twenty":-15.356229,"median":-10.681731,"eighty":-7.83714,"marketCap":13841623},{"date":"2024-05-31","current":-6.030941,"twenty":-15.281507,"median":-10.409864,"eighty":-6.954736,"marketCap":14459767},{"date":"2024-06-07","current":-4.748738,"twenty":-15.235078,"median":-10.159255,"eighty":-6.68061,"marketCap":11385560},{"date":"2024-06-14","current":-2.25909,"twenty":-15.107401,"median":-9.656887,"eighty":-6.509425,"marketCap":5416387},{"date":"2024-06-21","current":-1.821847,"twenty":-15.007495,"median":-8.940145,"eighty":-6.069835,"marketCap":4368054},{"date":"2024-06-28","current":-1.912311,"twenty":-14.84161,"median":-8.707933,"eighty":-5.984352,"marketCap":4584951},{"date":"2024-07-05","current":-1.595686,"twenty":-14.277975,"median":-8.24351,"eighty":-5.773123,"marketCap":3825813},{"date":"2024-07-12","current":-1.228176,"twenty":-14.247617,"median":-8.069351,"eighty":-4.748738,"marketCap":2944671},{"date":"2024-07-15","current":-1.226291,"twenty":-14.24184,"median":-8.069351,"eighty":-4.719086,"marketCap":2940152},{"date":"2024-08-02","current":-1.013952,"twenty":-14.236062,"median":-8.040325,"eighty":-4.535268,"marketCap":2431048},{"date":"2024-08-09","current":-0.885794,"twenty":-13.839564,"median":-8.011298,"eighty":-2.310102,"marketCap":2123778},{"date":"2024-08-16","current":-0.654013,"twenty":-13.158247,"median":-7.83714,"eighty":-1.891957,"marketCap":2229214},{"date":"2024-08-23","current":-2.636712,"twenty":-12.954324,"median":-7.140505,"eighty":-1.844463,"marketCap":7260829},{"date":"2024-08-30","current":-2.420589,"twenty":-12.883473,"median":-6.744599,"eighty":-1.891957,"marketCap":6665683},{"date":"2024-09-06","current":-2.068131,"twenty":-12.832404,"median":-6.687402,"eighty":-1.924373,"marketCap":5695102},{"date":"2024-09-13","current":-1.60378,"twenty":-12.678367,"median":-6.559976,"eighty":-1.829704,"marketCap":4416400},{"date":"2024-09-20","current":-1.622429,"twenty":-12.393993,"median":-6.417311,"eighty":-1.725453,"marketCap":4467754},{"date":"2024-09-27","current":-1.758564,"twenty":-12.190139,"median":-6.030941,"eighty":-1.729099,"marketCap":4842634},{"date":"2024-10-04","current":-1.723131,"twenty":-12.057464,"median":-5.826769,"eighty":-1.723525,"marketCap":4745063},{"date":"2024-10-11","current":-1.770191,"twenty":-11.67976,"median":-5.685419,"eighty":-1.725453,"marketCap":4874653},{"date":"2024-10-18","current":-1.640939,"twenty":-11.355145,"median":-5.192459,"eighty":-1.725453,"marketCap":4518726},{"date":"2024-10-25","current":-4.541316,"twenty":-11.227428,"median":-4.704227,"eighty":-1.717164,"marketCap":12505622},{"date":"2024-10-31","current":-4.448525,"twenty":-11.088102,"median":-4.448525,"eighty":-1.723131,"marketCap":12250098},{"date":"2024-11-08","current":-3.853568,"twenty":-10.85589,"median":-4.424907,"eighty":-1.725101,"marketCap":10611741},{"date":"2024-11-15","current":-10.217961,"twenty":-11.088102,"median":-4.448525,"eighty":-1.726861,"marketCap":28137649},{"date":"2024-11-22","current":-5.605162,"twenty":-11.378366,"median":-4.622772,"eighty":-1.72898,"marketCap":37261342},{"date":"2024-11-29","current":-5.285991,"twenty":-11.285481,"median":-4.70795,"eighty":-1.736236,"marketCap":29010326},{"date":"2024-12-06","current":-5.244908,"twenty":-11.122934,"median":-4.743697,"eighty":-1.739542,"marketCap":28784857},{"date":"2024-12-13","current":-1.906243,"twenty":-10.902332,"median":-4.70795,"eighty":-1.744391,"marketCap":10461755},{"date":"2024-12-20","current":-1.478982,"twenty":-10.729812,"median":-4.535858,"eighty":-1.726509,"marketCap":8116878},{"date":"2024-12-27","current":-2.097767,"twenty":-10.58386,"median":-4.43215,"eighty":-1.724313,"marketCap":11512866},{"date":"2025-01-03","current":-2.13273,"twenty":-10.499069,"median":-4.417664,"eighty":-1.725805,"marketCap":11704747},{"date":"2025-01-10","current":-1.293623,"twenty":-10.455734,"median":-4.2029,"eighty":-1.723525,"marketCap":7099600},{"date":"2025-01-17","current":-0.870573,"twenty":-10.310323,"median":-4.062655,"eighty":-1.649339,"marketCap":4777839},{"date":"2025-01-24","current":-0.821625,"twenty":-10.217961,"median":-3.965464,"eighty":-1.627827,"marketCap":4509205},{"date":"2025-01-31","current":-0.695759,"twenty":-10.19009,"median":-3.820818,"eighty":-1.596315,"marketCap":3818433},{"date":"2025-02-07","current":-0.713241,"twenty":-10.159255,"median":-2.907717,"eighty":-1.573503,"marketCap":3914374},{"date":"2025-02-14","current":-0.62933,"twenty":-10.101202,"median":-2.636712,"eighty":-1.510537,"marketCap":3453859},{"date":"2025-02-21","current":-0.716737,"twenty":-9.74575,"median":-2.540899,"eighty":-1.377788,"marketCap":3933562},{"date":"2025-02-28","current":-0.562901,"twenty":-9.640801,"median":-2.437302,"eighty":-1.224909,"marketCap":3089285},{"date":"2025-03-07","current":-0.510457,"twenty":-9.079472,"median":-2.372103,"eighty":-1.030709,"marketCap":2801464},{"date":"2025-03-14","current":-0.335713,"twenty":-8.754375,"median":-2.239137,"eighty":-0.96912,"marketCap":1842442},{"date":"2025-03-21","current":-0.335643,"twenty":-8.503123,"median":-2.198781,"eighty":-0.896348,"marketCap":1842058},{"date":"2025-03-28","current":-0.267465,"twenty":-8.285192,"median":-2.14239,"eighty":-0.857987,"marketCap":1467890},{"date":"2025-04-04","current":-0.24439,"twenty":-8.197068,"median":-2.097767,"eighty":-0.804927,"marketCap":1341248},{"date":"2025-04-11","current":-0.269213,"twenty":-8.092572,"median":-2.074831,"eighty":-0.719534,"marketCap":1477484},{"date":"2025-04-17","current":-0.137942,"twenty":-8.069351,"median":-2.037496,"eighty":-0.697857,"marketCap":1145530},{"date":"2025-04-25","current":-0.719207,"twenty":-8.034519,"median":-1.993365,"eighty":-0.682473,"marketCap":5972602},{"date":"2025-04-30","current":-0.614112,"twenty":-8.011298,"median":-1.966295,"eighty":-0.672684,"marketCap":5099849}],"updateTime":1746165515637}}}